Table 1.
Study | Database(s) | Date of Publication | Number of Included Studies | Number of Pregnant Women | Number of Newborns | Number of Infected Newborns | Maternal Deaths | Newborns Deaths | Cesarean Delivery | Remark (Vertical Transmission) | Sensitivity Analysis in Studies with Meta-Analysis |
---|---|---|---|---|---|---|---|---|---|---|---|
AbdelMassih et al. [19] | Embase, MEDLINE, Cochrane | April, 2021 | 64 | 1787 | 1787 | 45 (2.5) | NA | 19 | NA | Unlikely | Y |
Abdollahpour et al. [33] | PubMed, Scopus, Embase, Science direct, ClinicalKey, PsycINFO, manual searches of other relevant papers |
May, 2020 | 29 | NA | 2 | NA | NA | NA | NA | No direct evidence | NM |
Abou Ghayda et al. [16] | PubMed, Scopus, MEDLINE, Google Scholar, Embase | October, 2020 | 11 | 104 | NA | NA | NA | 6 (5.8) | 52 | Vertical infection was not found | NM |
Akhtar et al. [20] | MEDLINE, PubMed, Scopus, Google Scholar | July, 2020 | 22 | 156 | 108 | 7 | 8 | 3 | 66 | No evidence to support vertical transmission | NM |
Allotey et al. [22] | MEDLINE, Embase, Cochrane database, WHO COVID-19 database, CNKI, Wanfang, L·OVE |
September, 2020 | 77 | 11432 | NA | NA | <1% | <1% | 1060 (65% (57–73%) 95% CI) | Not reported | Y |
Amaral et al. [34] | Embase, PubMed database | November, 2020 | 70 | 1457 | 1042 | 39 (3.7%) | 15 (1%) | 16 (1.5%) | 15% | Low evidence to support vertical transmission | NM |
Arroyo-Sanchez et al. [34] | MEDLINE/PubMed, ScienceDirect, ClinicalKey, LILACS, SciELO, Google Scholar, medRxiv, and SciELO Preprints. |
2020 | 30 | 476 | 476 | 9 (1.9%) | Probable | NM | |||
Ashraf et al. [35] | PubMed, Scopus, WoS, Embase, Google Scholar | July–September, 2020 | 21 | 90 | 92 | 4 | 1 | 1 | 81 | Possible but rare | NM |
Banaei et al. [36] | MEDLINE, Embase, Scopus, WoS, ProQuest, Google Scholar |
2020 | 16 | 123 | 124 | 5 | 0 | 1 | 99 | Probable | NM |
Barcelos et al. [37] | PubMed, Scopus, Embase | Accepted November, 2020 | 27 | NA | NA | 9 | NA | NA | NA | Possible, with low risk | NM |
Bwire et al. [38] | PubMed/MEDLINE, Google Scholar | Accepted October, 2020 | 33 | 205 | 205 | 13 (6.3%) | NA | NA | 71.9% | Low possibility of vertical transmission | NM |
Cai et al. [39] | PubMed, Embase, Cochrane Library, Web of Science, Google Scholar, CBM | February, 2021 | 68 | 1019 | 1035 | 34 (3.29%) | 14 | 6 | 59.71% | Possible | NM |
Capobianco et al. [40] | PubMed, Scopus | Accepted July, 2020 | 13 | 114 | 108 | 5 | 0 | 2 | 95 | Low probability of vertical transmission | N |
Chamseddine et al. [41] | PubMed, medRxiv | October, 2020 | 48 | 245 | 201 | 6.45% | 8 (3.2%) | 2.5% | 89% | Possible | NM |
Chi et al. [42] | PubMed/MEDLINE, Embase, Cumulative Index to Nursing and Allied Health Literature, National Digital Library of Theses and Dissertations in Taiwan, Art Image Indexing Service on the Internet, Cochrane | February, 2021 | 14 | 107 | 105 | 8 (8.8%) | NA | NA | 87.6% | Possible | NM |
Della Gatta et al. [43] | PubMed, Scopus, CINAHL | July, 2020 | 6 | 51 | 48 | 1 | NA | 1 | 46 | No evidence of vertical transmission | NM |
Deniz & Tezer [44] | medRxiv, PubMed | July, 2020 | 50 | 714 | 606 | 20 | NA | NA | NA | Potentially vertically transmit-ted | NM |
Dhir et al. [45] | MEDLINE, Embase, Web of Science | August, 2020 | 86 | 1992 | 1141 | 58 | NA | 0 | 66% | Possible, with low risk | NM |
Di Mascio et al. [46] | MEDLINE, Embase, CINAHL, ClinicalTrials.gov | May, 2020 | 6 | 41 | 42 | 0 | 0 | 2.4% | 38 | None has been reported | N |
Di Toro et al. [25] | PubMed, Embase, medRxiv, Scholar, Scopus, Web of Science | January, 2021 | 24 | 588 | 444 | 19 | 5 | 3 | 85% | No evidence of vertical transmission | N |
Diriba et al. [47] | PubMed, Web of Science, Embase, Google Scholar, Cochrane | September, 2020 | 23 | 1271 | NA | 0 | 1.5% | 1.2% | 57% | No evidence of vertical transmission | Y |
Amaral et al. [34] | PubMed, Embase | November, 2020 | 70 | 1457 | 1112 | 39 | 15 | 16 | 597 (57.3%) | Possible | NM |
Dube et al. [48] | PubMed, Embase, LitCovid, medRxiv, bioRxiv, Google Scholar, EBSCO MEDLINE, CINAHL, Scopus | November, 2020 | 72 | NA | 1408 | 51 (3.67%) | NA | NA | 59.9% | Possible but low | NM |
Dubey et al. [49] | PubMed | September, 2020 | 61 | 790 | 548 | NA | NA | NA | 72% | None reported | Y |
Duran et al. [50] | Google Scholar, LILACS, PubMed | May, 2020 | 20 | 195 | 222 | 13 | NA | 1 | 48 | Probable | NM |
Elshafeey et al. [51] | LitCovid, EBSCO MEDLINE, CENTRAL, CINAHL, Web of Science, Scopus | May, 2020 | 33 | 385 | 256 | 4 | 1 | 1 | 175 (69.4) | Probable | NM |
Galang et al. [52] | MEDLINE, ClinicalTrials.gov | August, 2020 | 31 | 98 | 94 | 8 | 1 | 1 | 72 | Probable | NM |
Gao et al. [53] | PubMed, Web of Science, Embase, MEDLINE | August, 2020 | 14 | 236 | NA | 1.8% | NA | 1 | 69% | No evidence available | Y |
Ghayda et al. [16] | PubMed, Scopus, MEDLINE, Google Scholar, Embase | October, 2020 | 11 | 104 | NA | 0 | 7 | 5 fetal + 1 neonatal | 50% | No vertical transmission reported | N |
Gordon et al. [54] | CINAHL, Embase, MEDLINEMEDLINE, PubMed | May, 2020 | 8 | NA | 46 | 7 | NA | 0 | 86% | Likely | NM |
Han et al. [55] | MEDLINE, PubMed, Web of Science, Cochrane, CNKI, Wanfang Data, VIP, SinoMed, ClinicalTrials.gov | October, 2020 | 36 | 1103 | NA | <0.01% | <0.01% | <0.01% | 28.59% | Unlikely | NM |
Hassanipour et al. [56] | PubMed, Embase, Scopus, Web of Science, Google Scholar | December, 2020 | 10 | 135 | NA | 1 | NA | 1 | 84% | Low evidence for vertical transmission | N |
Huntley et al. [57] | MEDLINE, Ovid, ClinicalTrials.gov, medRxiv, Scopus |
August, 2020 | 13 | 538 | 435 | 0 | 0 | 1 | 85% | None reported | NM |
Islam et al. [58] | PubMed, Embase, Scopus, Google Scholar, Web of Science |
December, 2020 | 13 | 235 | NA | 0 | NA | NA | 156 (66.38%) | Not reported | N |
Jafari et al. [59] | Embase, Scopus, PubMed, Web of Science, Cochrane | January, 2021 | 121 | NA | 8% | NA | NA | 2.5% | 48% | Possible | N |
Juan et al. [60] | PubMed, Embase, Cochrane, CNKI, Wanfang Data | May, 2020 | 24 | 324 | 240 | 3 | 7 | 1 | 78.1% | Possible | NM |
Karabay et al. [61] | MEDLINE, Web of Science, PubMed, ScienceDirect, CINAHL, Scopus, Cochrane, TUBiTAK | November, 2020 | 35 | NA | NA | 68 | NA | 0 | NA | Possible | NM |
Kasraeian et al. [62] | PubMed, Google Scholar, medRxiv, UpToDate search engines | May, 2020 | 9 | 87 | 86 | 0 | 0 | 0.2% | 92.2% | Not reported | Y |
Khalil et al. [63] | MEDLINE, Embase, ClinicalTrials.gov, Cochrane | August, 2020 | 86 | 2567 | NA | 1.4% | 0.9% | 0.6% | 48.3% | Possible | N |
Kotlyar et al. [13] | PubMed, Embase, medRxiv, bioRxiv | Jan, 2021 | 69 | 1566 | 936 | 27 (3.2%) | NA | NA | 73% | Possible | Y |
Lopes de Sousa et al. [64] | PubMed, Scopus, Embase, ScienceDirect, WoS, Google Scholar, bioRxiv, medRxiv |
June, 2020 | 49 | 755 | 598 | 1.8% | 8 | 10 | 64.7% | No concrete evidence of vertical transmission | NM |
Matar et al. [65] | Ovid MEDLINE and Epub Ahead of Print, In-Process and Other Nonindexed Citations, Ovid Embase, Ovid Cochrane Central Register of Controlled Trials, Scopus |
June, 2020 | 24 | 136 | 94 | 2 | 1 | 3 | 76.3% | Probable | N |
Melo et al. [66] | PubMed, Scopus, LILACS, Web of Science, Google Scholar, Preprints, bioRxiv, medRxiv | July, 2020 | 38 | 520 | NA | 16 | NA | NA | NA | Possible | Y |
Mirbeyk et al. [67] | PubMed, Web of Science, Google Scholar, Scopus, WHO COVID-19 database | April, 2021 | 37 | 386 | 302 | 5% | 2 | 3 | 86% | Possible, with low evidence | NM |
Muhidin et al. [68] | PubMed, Scopus, Embase, ProQuest, ScienceDirect | April, 2020 | 9 | 89 | 89 | 0 | 0 | 2.2% | 91.9% | No evidence | NM |
Najafi et al. [69] | PubMed, Scopus, Google Scholar | December, 2020 | 20 | NA | 145 | 7 | NA | 10% | NA | Low risk of vertical transmission | NM |
Neef et al. [70] | PubMed, Google Scholar, Web of Science | October, 2020 | 32 | 258 | 261 | 12 | NA | 3 | NA | The risk of vertical transmission is low | N |
Novoa et al. [21] | MEDLINE, Embase, Cochrane Library, LILACS, CNKI, VIP, Wanfang Data | January–February, 2021 | 37 | 322 | 195 | 16 | 1 | 1 | 99 (50.8%) | No concrete evidence to support vertical transmission | N |
Oltean et al. [71] | MEDLINE, Embase, Google Scholar, WHO database on COVID-19, Disaster Lit: Database, medRxiv, and OSF Preprints | March, 2021 | 41 | 315 | 262 | 3.1% | NA | 1 | NA | Vertical transmission has yet to be confirmed | NM |
Oshay et al. [72] | PubMed, Embase, World Health Organization, Google Scholar | July, 2021 | 67 | 427 | 304 | 3.2% | 8 | NA | NA | Low risk of vertical transmission | NM |
Papapanou et al. [17] | PubMed, Scopus, Cochrane | January, 2021 | 39 | NA | NA | 1.6–10% | <2% | <3% | 52.3–95.8% | Probable | NM |
Pastick et al. [73] | PubMed/MEDLINE | August, 2020 | 126 | 11308 | 10597 | NA | 33 | 0.7% | 70% | Not reported | NM |
Pettirosso et al. [74] | MEDLINE, Embase, WHO COVID-19 database, Cochrane | August, 2020 | 60 | 1287 | NA | 19 | 8 | 6 | NA | Possible | NM |
Raschetti et al. [75] | PubMed, Cochrane, Web of Science, bioRxiv, and medRxiv | October, 2020 | 74 | NA | NA | 53 | NA | NA | NA | Confirmed/possible | N |
Rodrigues et al. [76] | PubMed, Scopus, Web of Science, medRxiv | November, 2020 | 161 | 3985 | 2015 | 61 | 28 | 10 | 53.92% | Possible | NM |
Smith et al. [23] | PubMed, MEDLINE, Embase | June, 2020 | 9 | 92 | 60 | 1 | 0 | 1 | 80% | Probable | NM |
Thomas et al. [77] | Ovid MEDLINE, Embase, CENTRAL | July, 2020 | 18 | 157 | 160 | 5 | 1 | 1 | 115 (73%) | No conclusive evidence to support vertical transmission | NM |
Tolu et al. [24] | PubMed, CINAHL, Web of Science, Scopus, CENTRAL | April, 2021 | 51 | NA | 336 | 15 | NA | NA | 265 (78.8%) | Not enough evidence on vertical transmission | NM |
Trippella et al. [78] | MEDLINE, Embase, Google Scholar, medRxiv | June, 2020 | 37 | 275 | 248 | 16 | 1 | 1 | 74.9% | Possible | NM |
Trocado et al. [79] | PubMed, Scopus database, and WHO database | July, 2020 | 8 | 95 | 51 | 1 | 0 | 1 | 94% | Probable | NM |
Turan et al. [80] | PubMed, Ovid MEDLINE, WoS, China Academic Literature Database |
July, 2020 | 63 | 637 | 479 | 8 | 10 | 5 | 83% | Probable | NM |
Vergara-Merino et al. [18] | PubMed/MEDLINE, Embase, other electronic databases, clinical trials registries, and preprint repositories, among other sources relevant to COVID-19 | February, 2021 | 52 | NA | NA | 0–11.5% | 0–11.1% | 0–11.7% | 48.3–100% | Possible | NM |
Walker et al. [81] | MEDLINE, Embase, Maternity and Infant Care Database | June, 2020 | 49 | 655 | 666 | 28 | NA | NA | 5.3% | Probable | NM |
Yang et al. (a) [82] | PubMed, Google Scholar, CNKI, Wanfang Data, VIP, CBMdisc |
April, 2020 | 18 | 114 | NA | 7 | NA | 1 | 90.8% | No direct evidence | NM |
Yang et al. (b) [83] | PubMed, CNKI, CBMdisc, Wanfang Data | 2020 | 22 | NA | 83 | 9 | NA | NA | 88% | No direct evidence | NM |
Yee et al. [84] | PubMed, Embase, WoS | October, 2020 | 9 | 93 | 103 | 4 | NA | 0 | NA | No direct evidence | N |
Yoon et al. [85] | PubMed/MEDLINE, Embase | 2020 | 28 | 223 | 201 | 4 | NA | 1 | 88.1% | Probable | NM |
Yuan et al. [86] | PubMed, MEDLINE, CBM, Wanfang | 2021 | 29 | 564 | 555 | 18 | NA | NA | 62.8% | No sufficient evidence to exclude the possibility of vertical transmission | NM |
Zaigham et al. [87] | MEDLINE, Embase, Google Scholar | April, 2020 | 18 | 108 | 87 | 1 | 0 | 1 | 92% | Probable | NM |
Abbreviation: NA: Not available; Remark: Conclusion remarks drawn from the included systematic reviews studies on vertical transmission of SARS-CoV-2; Y: Yes; N: No; NM: No Meta-analysis.